Accel led a $85m Series C round in Truemeds.

Accel, an early and growth-stage venture capital firm, led a $85m Series C round in Truemeds, an online pharmacy specializing in personalized medicine solutions, with participation from Peak XV Partners, WestBridge, InfoEdge Ventures. "India's healthcare market is undergoing rapid transformation, yet affordability continues to be a major barrier, especially in chronic care. Truemeds is bridging this gap with a clinically guided, technology-led platform that delivers transparency and accessibility at scale," Abhinav Chaturvedi, Accel Partner.